INTERNATIONAL DIABETES SUMMIT 2020 VIDEOS
Two unusual and challenging diabetes cases By Dr Vijay Negalur
Two unusual and challenging diabetes cases By Dr Vijay Negalur
Case studies of diabetes management in frail, elderly people By Dr V Abichandani
Case studies of diabetes management in frail, elderly people By Dr V Abichandani
Case based perspectives in GDM: focus on diagnosis and therapy By Dr Rakesh Sahay
Case based perspectives in GDM: focus on diagnosis and therapy By Dr Rakesh Sahay
Corona Virus infection in people with diabetes and other comorbidities By Dr Bharat Purandre
Corona Virus infection in people with diabetes and other comorbidities By Dr Bharat Purandre
Cases of diabetic retinopathy: what should a physician know? By Dr SAVITA BHAT
Cases of diabetic retinopathy: what should a physician know? By Dr SAVITA BHAT
Case studies in diabetic nephropathy By Dr Manisha Sahay
Case studies in diabetic nephropathy By Dr Manisha Sahay
Anti-platelet therapy in diabetes: where are we now By Dr KAUSHIK RAY
Anti-platelet therapy in diabetes: where are we now By Dr KAUSHIK RAY
New understanding of type 2 diabetes, a reversible condition By Dr ROY TAYLOR
New understanding of type 2 diabetes, a reversible condition By Dr ROY TAYLOR
Achieving diabetes remission in the real world By Dr ROY TAYLOR
Achieving diabetes remission in the real world By Dr ROY TAYLOR
Vegan versus vegetarian diets: a critical look By Dr Neeta Deshpande
Vegan versus vegetarian diets: a critical look By Dr Neeta Deshpande
Ketodiet: a practical perspective + case studies By Dr Rucha Mehta
Ketodiet: a practical perspective + case studies By Dr Rucha Mehta
Demonstration of carbohydrate samples By Dr Vedavati Purandare
Demonstration of carbohydrate samples By Dr Vedavati Purandare
What is a "carb" and how is it counted? By Rutuja Mahajan
What is a "carb" and how is it counted? By Rutuja Mahajan
The renaissance of sulfonylurea therapy By Dr MATHEW JOHN
The renaissance of sulfonylurea therapy By Dr MATHEW JOHN
Glimepiride: the CAROLINA surprise By Dr KARTHIK BALACHANDRAN
Glimepiride: the CAROLINA surprise By Dr KARTHIK BALACHANDRAN
Metformin in GDM management By Dr ANITA NAMBIAR
Metformin in GDM management By Dr ANITA NAMBIAR
DPP4i in clinical practice: are there more differences than we thought? By Dr SAMIT GHOSAL
DPP4i in clinical practice: are there more differences than we thought? By Dr SAMIT GHOSAL
Vasculo metabolic effects with glucose lowering therapies, place of SGLT2i By Dr HEMRAJ CHANDALIA
Vasculo metabolic effects with glucose lowering therapies, place of SGLT2i By Dr HEMRAJ CHANDALIA
Evolving evidence with DPP4i: implications to practice By Dr ARPANDEV BHATTACHARYA
Evolving evidence with DPP4i: implications to practice By Dr ARPANDEV BHATTACHARYA
Glycaemia control and cardiovascular outcomes By Dr TINY NAIR
Glycaemia control and cardiovascular outcomes By Dr TINY NAIR
VERIFY: The India sub-analysis By Dr UDAY PHADKE
VERIFY: The India sub-analysis By Dr UDAY PHADKE
Translating ADVANCE trial benefits into clinical practice By Dr Murali K Ganguri
Translating ADVANCE trial benefits into clinical practice By Dr Murali K Ganguri
What's new about alogliptin - examining the EXAMINE trial By Dr Ameya Joshi
What's new about alogliptin - examining the EXAMINE trial By Dr Ameya Joshi
Using clinical trials to choose DPP4i therapy: focus on case studies By Dr MANOJ CHAWLA
Using clinical trials to choose DPP4i therapy: focus on case studies By Dr MANOJ CHAWLA
Psychosocial aspects of diabetes - a unique India perspectiveBy Dr ARCHANA SARDA
Psychosocial aspects of diabetes - a unique India perspectiveBy Dr ARCHANA SARDA
Glucose targets in non-critically ill subjects: case study By Dr ARUN MEMON
Glucose targets in non-critically ill subjects: case study By Dr ARUN MEMON
Glucose targets in critically ill: case based learning By Dr Sanjay Agarwal
Glucose targets in critically ill: case based learning By Dr Sanjay Agarwal
Glucose control in hospitalised people - introductory case By Dr.VEDANTI PURANDARE & ASHUTOSH PAKALE
Glucose control in hospitalised people - introductory case By Dr.VEDANTI PURANDARE & ASHUTOSH PAKALE
Glycemic management in diabetic foot with chronic kidney disease By Dr ANJALI BHATT
Glycemic management in diabetic foot with chronic kidney disease By Dr ANJALI BHATT
CGM for in-hospital care: an experimental tool By Dr RAJESH JAVHERANI
CGM for in-hospital care: an experimental tool By Dr RAJESH JAVHERANI
Complications screening program in a diabetes clinic By Dr A G Unnikrishnan
Complications screening program in a diabetes clinic By Dr A G Unnikrishnan
Running a successful diabetes clinic - what are the basics to know? By Dr K Srikanth
Running a successful diabetes clinic - what are the basics to know? By Dr K Srikanth
Incorporating innovations in day to day practice By Dr Sunil M Jain
Incorporating innovations in day to day practice By Dr Sunil M Jain
Introduction to Time-In-Range By Dr A G Unnikrishnan
Introduction to Time-In-Range By Dr A G Unnikrishnan
Time-In-Range vs HbA1c - Why TIR is a must in today's era? By Dr Banshi Saboo
Time-In-Range vs HbA1c - Why TIR is a must in today's era? By Dr Banshi Saboo
AGP & TIR correlation; managing T1 & T2 is now easy! - case presentation By Dr Kalyan Chakravarthy
AGP & TIR correlation; managing T1 & T2 is now easy! - case presentation By Dr Kalyan Chakravarthy
Applying new subclinical hypothyroidism guidelines: case Studies By Dr KARTHIK BALCHANDRAN
Applying new subclinical hypothyroidism guidelines: case Studies By Dr KARTHIK BALCHANDRAN
Challenges in the management of hypothyroidism By Dr Uday Phadke
Challenges in the management of hypothyroidism By Dr Uday Phadke
ITS FOGSI recommendations on thyroid disorders and pregnancy By Dr Altamash Shaikh
ITS FOGSI recommendations on thyroid disorders and pregnancy By Dr Altamash Shaikh
Anti-thyroid drugs how much and how long? By Dr Arpandev Bhattacharya
Anti-thyroid drugs how much and how long? By Dr Arpandev Bhattacharya
Choosing anti-diabetes agents for the best CV outcome By Dr BINAYAK SINHA
Choosing anti-diabetes agents for the best CV outcome By Dr BINAYAK SINHA
SGLT2i and renal outcomes in diabetes: what is new? By Dr K Srikanth
SGLT2i and renal outcomes in diabetes: what is new? By Dr K Srikanth
Heart failure in diabetes: what's new for the diabetologist? By Dr C K Pondey
Heart failure in diabetes: what's new for the diabetologist? By Dr C K Pondey
Kidney as a window to heart: further analysis from CREDENCE By Dr Awadhesh Kumar Sing
Kidney as a window to heart: further analysis from CREDENCE By Dr Awadhesh Kumar Sing
Emerging concepts in the management of hypertension in diabetes By Dr Tiny Nair
Emerging concepts in the management of hypertension in diabetes By Dr Tiny Nair
Standard of care in post ACS patient - A guideline based approach By Dr M S Hiremath
Standard of care in post ACS patient - A guideline based approach By Dr M S Hiremath
Treat to prevent CV renal disease progression in diabetes - a paradigm shift By Dr Mangesh Tiwaskar
Treat to prevent CV renal disease progression in diabetes - a paradigm shift By Dr Mangesh Tiwaskar
Lipids and CVD- the importance of treating to risk By Dr KAUSHIK RAY
Lipids and CVD- the importance of treating to risk By Dr KAUSHIK RAY
Heart failure and diabetes By Dr SHAILAJA KALE
Heart failure and diabetes By Dr SHAILAJA KALE
Medical management of heart failure By Dr SUNIL SATHE
Medical management of heart failure By Dr SUNIL SATHE
Diabetes & heart failure - a deadly combination By Dr Uday Phadke
Diabetes & heart failure - a deadly combination By Dr Uday Phadke
SGLT2i - efficacy and safety in clinical practice By Dr Shailaja Kale
SGLT2i - efficacy and safety in clinical practice By Dr Shailaja Kale
SGLT2i : from prevention to treatment By Dr Samit Ghosal
SGLT2i : from prevention to treatment By Dr Samit Ghosal
GLP 1 in cardiovascular diabetology By Dr BINAYAK SINHA
GLP 1 in cardiovascular diabetology By Dr BINAYAK SINHA
Addressing inertias to injections with once weekly options in type 2 diabetes By Dr Rajiv Kovil
Addressing inertias to injections with once weekly options in type 2 diabetes By Dr Rajiv Kovil
How to interpret autoantibody positivity?By Dr C B SANJEEVI
How to interpret autoantibody positivity?By Dr C B SANJEEVI
The case for pumps + CGMS in all type 1 diabetes By Dr Mohan Shenoy
The case for pumps + CGMS in all type 1 diabetes By Dr Mohan Shenoy
Type 1 diabetes may be managed with SMBG + MDI By Dr Ganesh Jevalikar
Type 1 diabetes may be managed with SMBG + MDI By Dr Ganesh Jevalikar
Non-insulin management of type 1 diabetes: what is the latest? By Dr ANANDA BASU
Non-insulin management of type 1 diabetes: what is the latest? By Dr ANANDA BASU
Popular Courses
Rated 5 out of 5 based on 5 customer ratings
₹2,900.00
Rated 5 out of 5 based on 5 customer ratings
₹7,000.00
Rated 5 out of 5 based on 5 customer ratings
₹4,900.00
Rated 5 out of 5 based on 5 customer ratings
₹2,900.00
Rated 5 out of 5 based on 5 customer ratings
₹1,950.00
Sign up to receive our latest updates
- © 2024 Chellaram Diabetes Institute.All rights reserved.